Sareh Parangi

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 5

Top Topics

Regulatory T Cells

Top Venues

Science advances

British journal of cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Hui-Yu Hu, Thomas S C Ng, Mikyung Kang, Ella Scott, Ran Li, Jeremy M Quintana, Dylan Matvey, Venkata R Vantaku, Ralph Weissleder, Sareh Parangi, Miles A Miller
Thyroid cancers exhibit oncogene-enhanced macropinocytosis that is restrained by IGF1R and promotes albumin-drug-conjugate response. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Raj K Gopal, Venkata R Vantaku, Apekshya Panda, Bryn Reimer, Sneha Rath, Tsz-Leung To, Adam S Fisch, Murat Cetinbas, Maia Livneh, Michael J Calcaterra, Benjamin J Gigliotti, Kerry A Pierce, Andrew T Chan, Dora Dias-Santagata, Peter M Sadow, Lori J Wirth, Gilbert H Daniels, Ruslan I Sadreyev, Sarah E Calvo, Sareh Parangi, Vamsi K Mootha
Effectors enabling adaptation to mitochondrial complex I loss in Hurthle cell carcinoma. Cancer discovery (2023)
Thomas S C Ng, Hui-Yu Hu, Stefan Kronister, Chanseo Lee, Ran Li, Luca Gerosa, Sylwia A Stopka, Danielle M Burgenske, Ishaan Khurana, Michael S Regan, Sreeram Vallabhaneni, Niharika Putta, Ella Scott, Dylan Matvey, Anita Giobbie-Hurder, Rainer H Kohler, Jann N Sarkaria, Sareh Parangi, Peter Karl Sorger, Nathalie Y R Agar, Heather A Jacene, Ryan J Sullivan, Elizabeth Buchbinder, Hannes Mikula, Ralph Weissleder, Miles A Miller
Overcoming differential tumor penetration of BRAF inhibitors using computationally guided combination therapy. Science advances 8 (17) (2022)
Viswanath Gunda, Benjamin J Gigliotti, Tameem Ashry, Dorothy Ndishabandi, Michael McCarthy, Zhiheng Zhou, Salma Amin, Kyu Eun Lee, Tabea Stork, Lori Wirth, Gordon J Freeman, Alessandro Alessandrini, Sareh Parangi
Anti-PD-1/PD-L1 therapy augments lenvatinib's efficacy by favorably altering the immune microenvironment of murine anaplastic thyroid cancer. International journal of cancer 144 (9) (2019)
Viswanath Gunda, Benjamin Gigliotti, Dorothy Ndishabandi, Tameem Ashry, Michael McCarthy, Zhiheng Zhou, Salma Amin, Gordon J Freeman, Alessandro Alessandrini, Sareh Parangi
Combinations of BRAF inhibitor and anti-PD-1/PD-L1 antibody improve survival and tumour immunity in an immunocompetent model of orthotopic murine anaplastic thyroid cancer. British journal of cancer 119 (10) (2018)